Health information site HealthCentral has been acquired by Remedy Health, a multimedia provider of content and tools designed to help people manage disease, the firms said today.
Pri-Med founder John Mooney and his former management team have returned to the firm, which is under new ownership following M|C Holding’s sale of Pri-Med’s US assets to Canadian event and media producer Diversified Business Communications.
No ‘pent-up demand’ for cancer med Jakafi, Incyte says
The launch of new cancer pill Jakafi will require extensive education, said Incyte Pharmaceuticals, owing partly to low awareness levels among doctors.
Springer in deal to buy Wolters Kluwer pharma-related journals
Wolters Kluwer reached an agreement to sell its pharma-related marketing and publishing services unit to Springer Science+Business Media, the firms said today.
Amylin, parting ways with Lilly, plans for extra sales reps
Amylin said it will hire 365 sales reps to make up for Eli Lilly’s departure from commercial activities, once the firm takes full control of the exenatide diabetes franchise in the US this month.
Johnson & Johnson/Bayer’s Xarelto (rivaroxaban) received FDA approval for stroke prevention in atrial fibrillation (SPAF), the second novel anticoagulant to gain US marketing approval for SPAF.
GSK hopes $3-bil. off-label settlement will end legal woes
GlaxoSmithKline’s deal to resolve multiple US investigations into its sales and marketing practices—one of the largest settlements by a pharma company—aims to patch up several long-running legal disputes.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix